08:29 AM EDT, 04/09/2026 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) said Thursday that it has signed a strategic collaboration agreement with Precision Health Research, Singapore, to advance the PRECISE-SG100K study.
Financial terms were not disclosed.
The company said the study is monitoring long-term health outcomes related to environmental, lifestyle, and genetic factors associated with diseases such as diabetes, hypertension, and cancer.